{"id":312218,"date":"2019-01-04T23:07:02","date_gmt":"2019-01-04T23:07:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=312218"},"modified":"2019-01-04T23:07:02","modified_gmt":"2019-01-04T23:07:02","slug":"retinal-vein-occlusion-rvc-market-2018-global-overview-geographics-analysis-recent-trends-top-players-business-analysis-industry-dynamics-and-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/retinal-vein-occlusion-rvc-market-2018-global-overview-geographics-analysis-recent-trends-top-players-business-analysis-industry-dynamics-and-forecast-to-2023_312218.html","title":{"rendered":"Retinal Vein Occlusion (RVC) Market 2018 Global Overview, Geographic\u2019s Analysis, Recent Trends, Top Players, Business Analysis, Industry Dynamics and Forecast to 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Retinal Vein Occlusion Market”<\/div>\n<\/div>\n<\/div>\n
The Report of Global Retinal Vein Occlusion Market by Market Research Future Covers the Information like Retinal Vein Occlusion Market Growth, Top 10 Players, Upcoming Trends, chapter-wise Description followed by various user perceptions.\n<\/div>\n

Retinal Vein Occlusion Market – Synopsis<\/strong><\/p>\n

Retinal vein occlusion (RVO), which is also popularly known as eye stroke is a disorder that happens when a vein in the retina gets blocked because of a blood clot. The retina is hugely vital to the eyesight thus blockage here can result in permanent blindness or loss of vision.<\/p>\n

Some of the risk factors associated with RVO include age, hypertension, hyperlipidaemia, diabetes mellitus, oral contraceptive pill, raised intraocular pressure and smoking. Often older people with atherosclerosis and high blood pressure are diagnosed with retinal vein occlusion. After diabetic retinopathy, it is the second leading cause of blindness.<\/p>\n

Request Sample Copy at<\/strong> https:\/\/www.marketresearchfuture.com\/sample_request\/5377<\/a><\/p>\n

Following the cumulative occurrence of eye disorders and chronic disorders especially diabetes which is the principal contributor, the market for RVO is predicted to grow exponentially. Market Research Future (MRFR) projects that the global market for retinal vein occlusion is likely to grow at 11.2% CAGR during the prediction period 2017-2023.<\/p>\n

Retinal Vein Occlusion Market – Segmentation<\/strong><\/p>\n

In MRFR’s report, the global market for retinal vein occlusion is segmented on the basis of  type, condition, diagnosis, treatment and end users.<\/p>\n

Based on type, the market has been segmented into Central Retinal Vein Occlusion and Branch Retinal Artery Occlusion. Central Retinal Vein Occlusion called CRVO, this is a condition where the central vein which drains blood from an eye’s retina closes off entirely or partially.  The common symptoms here is a blurry vision in the entire eye or just a part or vision loss. People at the risk of getting CRVO are those with glaucoma, diabetes, high blood pressure, and arteriosclerosis.  Branch Retinal Artery Occlusion is a condition where there is reduced arterial blood flow into the retina resulting in ischemic damage. Here the severity of the loss of vision rests on the affected area of the retinal tissue due to vascular occlusion.<\/p>\n

Based on condition, the market has been segmented into Non-ischemic and Ischemic<\/p>\n

Based on the diagnosis, the market has been segmented into Fluorescein Angiography, Fundoscopic Examination, Optical Coherence Tomography (OCT) amid others.<\/p>\n

Based on treatment, the market has been segmented into Laser Retinal Photocoagulation, Corticosteroid Drugs, Antivascular Endothelial Growth Factor amid others.<\/p>\n

Based on end users, the market has been segmented into Academic and research centers, Clinics, Hospitals amid Others.<\/p>\n

Retinal Vein Occlusion Market – Regional Analysis<\/strong><\/p>\n

The Americas dominate the global market for retinal vein occlusion due to factors such as rising number of patients, existence of prominent market players, enhancement in surgical outcomes, increased emphasis on updating technology, availability of new and cutting-edge methods to treat RVO and the existence of an economic condition that is enough strong.<\/p>\n

Check Discount at<\/strong> https:\/\/www.marketresearchfuture.com\/check-discount\/5377<\/a><\/p>\n

In this market, Europe grabs the second position. This can be attributed to factors such as rising government support, high expenditure on healthcare and the existence of a massive geriatric population. As stated by OECD or the Organization for Economic Co-operation and Development, in Germany the expense made on healthcare was recorded as EUR 321 billion while the health care expenditure of France was the second highest with EUR 237 billion.<\/p>\n

It is the Asia Pacific that is the most rapidly growing market for RVO, this can be linked with the presence of several fast-developing nations in this region. Countries such as China and India are inspiring the growth of the market in APAC.<\/p>\n

The Middle East & Africa (MEA) region holds a relatively smaller share of market due to the lack of effective healthcare systems along with poor penetration of medical services. However, countries such as Kuwait and Qatar are paying attention to the healthcare domain and developing medical facilities to improve healthcare infrastructure – a silver lining for market players operating in the region.<\/p>\n

Retinal Vein Occlusion Market – Prominent Players <\/strong><\/p>\n

The leading players profiled in the report include Annexin Pharmaceuticals AB, Aerpio Therapeutics Inc, AstraZeneca, Pfizer Inc, Teva Pharmaceutical, Johnson & Johnson Sevices, Inc, Ranbaxy Pharmaceuticals, Genetec, Inc, Suzuken Co. Ltd, Icon Biosciences, Fovea Pharmaceuticals SA, Alimera Sciences, Valeant Pharmaceuticals, Sanofi Aventis, Lumenis, ZEISS, Topcon Medical Systems, Inc, Quantel Medical Inc, Novartis, IRIDEX Corporation, GlaxoSmithKline Plc, Ellex Medical Lasers, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Bayer and Allergan.<\/p>\n

Brief TOC of Retinal Vein Occlusion Market Research Report – Global Forecast till 2023:<\/strong><\/p>\n

1 Report Prologue<\/p>\n

2 Market Introduction<\/p>\n

3 Research Methodology<\/p>\n

4 Market Dynamics<\/p>\n

5 Market Factor Analysis<\/p>\n

6 Global Retinal Vein Occlusion Market, By Type<\/p>\n

7 Global Retinal Vein Occlusion Market, By Condition<\/p>\n

8 Global Retinal Vein Occlusion Market, By Diagnosis<\/p>\n

TOC CONTINUED…!<\/strong><\/p>\n

Browse Complete 150 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at <\/strong>https:\/\/www.marketresearchfuture.com\/reports\/retinal-vein-occlusion-market-5377<\/a><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/retinal-vein-occlusion-market-5377<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Retinal Vein Occlusion Market” The Report of Global Retinal Vein Occlusion Market by Market Research Future Covers the Information like Retinal Vein Occlusion Market Growth, Top 10 Players, Upcoming Trends, chapter-wise Description followed by various user perceptions. Retinal Vein Occlusion … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-312218","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/312218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=312218"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/312218\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=312218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=312218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=312218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}